+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Atracurium Market - Global Forecast 2025-2030- Product Image
Atracurium Market - Global Forecast 2025-2030- Product Image
Sale

Atracurium Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6013935
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Atracurium Market grew from USD 242.31 million in 2024 to USD 251.75 million in 2025. It is expected to continue growing at a CAGR of 3.78%, reaching USD 302.90 million by 2030.

Revealing the Critical Role and Mechanisms of Atracurium in Modern Clinical Care Settings to Set the Stage for In-Depth Market Evaluation

Atracurium stands as a foundational neuromuscular blocking agent in critical care and operative environments, underpinning modern patient management strategies. Its unique mechanism of action facilitates precise muscle relaxation without reliance on hepatic or renal clearance, offering a therapeutic advantage when organ function may be compromised. Emerging evidence highlights its metabolic profile, characterized by Hofmann elimination and ester hydrolysis, which supports predictable pharmacokinetics under fluctuating physiological conditions.

Within intensive care units, atracurium ensures optimal ventilatory synchrony, while in the surgical theatre it enhances procedural efficiency and patient safety. Historically, its adoption has coincided with advancements in anesthesia monitoring technologies, enabling anesthesiologists to tailor dosing to individual neuromuscular response. This introduction serves to orient readers to the multifaceted role of atracurium, establishing a foundation for a nuanced exploration of market dynamics, regulatory shifts, and strategic imperatives that follow in subsequent sections.

Exploring Paradigm-Shifting Developments in Atracurium Applications and Technologies That Are Reshaping Patient Outcomes and Clinical Practices Across Healthcare

Over recent years, the atracurium landscape has witnessed paradigm-shifting innovations in formulation, delivery, and clinical applications. Technological progress in infusion pumps and neuromuscular monitoring devices has enabled more precise dosing regimens, reducing recovery times and enhancing overall patient throughput. Concurrently, integration of digital analytics into anesthesia workflows has introduced predictive algorithms that optimize dosing schedules based on individual response profiles.

Regulatory developments have further accelerated transformation, as agencies globally implement more stringent safety and labeling requirements to mitigate adverse events. This evolving compliance framework has prompted manufacturers to invest in adaptive manufacturing processes and pharmacovigilance programs. As a result, the competitive environment is rapidly shifting, with new entrants focusing on niche applications and value-added services to differentiate their offerings. Through these shifts, stakeholders are compelled to reassess long-term strategies and realign resource allocation in anticipation of sustained market evolution.

Analyzing the Consequential Effects of Newly Imposed United States Tariffs in 2025 on Atracurium Supply Chains Cost Structures and Market Dynamics

The introduction of United States tariffs in 2025 has produced notable implications for the atracurium supply chain and cost structures. Manufacturers reliant on imported raw materials have encountered higher input expenses, necessitating renegotiation of supplier contracts and exploration of alternative sourcing strategies. In parallel, distributors and end users have faced elevated acquisition costs, prompting reevaluation of inventory management and procurement cycles to maintain operational efficiency without compromising patient care.

These tariff-induced adjustments have also catalyzed strategic collaborations among regional producers seeking to mitigate exposure to cross-border levies. By fostering localized production capabilities and co-manufacturing agreements, stakeholders aim to secure continuity of supply and preserve margin stability. As a byproduct, the market is experiencing a gradual shift toward vertically integrated models, underscoring the importance of supply chain resilience in the face of evolving trade policies and macroeconomic uncertainties.

Unveiling Deep-Dive Segmentation Perspectives Across Diverse Applications End Users Distribution Channels Forms and Administration Routes to Illuminate Key Market Drivers

A multifaceted examination of market segmentation for atracurium reveals diverse drivers across application domains, end users, distribution channels, dosage forms, and administration routes. In the realm of clinical applications, intensive care scenarios encompass both diagnostic procedures and mechanical ventilation support, while surgical interventions span cardiovascular surgery, general surgery, neurological surgery, and orthopedic surgery. Each subdomain exhibits distinct utilization patterns tied to patient acuity levels and procedural complexity.

Turning to end users, ambulatory surgery centers include hospital affiliated centers and standalone centers, clinics are differentiated into general clinics and specialty clinics, and hospitals comprise both private and public institutions. These settings dictate procurement protocols and volume commitments, influencing manufacturer engagement strategies. Distribution channels further diversify through hospital pharmacies offering in-house and outsourced options, online pharmacies segmented by over-the-counter and prescription fulfillment, and retail pharmacies categorized as chain or independent operators.

Form preferences bifurcate into lyophilized powder presentations available in multi-dose vials and single-dose vials, alongside pre-filled syringes configured as single-dose syringes. Administration practices center exclusively on intravenous delivery, with clinicians opting for either bolus injection or continuous infusion based on procedural demands and patient profiles. Collectively, these segmentation layers inform targeted marketing approaches and resource allocation decisions.

Dissecting Integral Regional Variations and Strategic Insights Across Americas Europe Middle East Africa and Asia Pacific for Atracurium Market Performance

Regional analysis highlights distinct trends and strategic considerations across the Americas, Europe Middle East and Africa, and Asia-Pacific territories. In the Americas, established infrastructure coupled with mature healthcare systems supports stable demand for atracurium, with emphasis on advanced intensive care protocols in leading markets. Cost containment measures continue to shape purchasing behaviors, prompting emphasis on value-based contracting and long-term supply agreements.

Within Europe Middle East and Africa, regulatory convergence and evolving reimbursement frameworks create both opportunities and challenges. Western European markets display rigorous quality standards and price sensitivity, while emerging economies in the region focus on expanding access and bolstering critical care capacity. Collaborative initiatives aimed at harmonizing clinical guidelines are enhancing cross-border knowledge transfer and driving incremental demand.

The Asia-Pacific landscape is characterized by rapid modernization of hospital networks and increasing adoption of specialized surgical services. Countries across this region are investing heavily in healthcare infrastructure upgrades, expanding the reach of intensive care units and surgical centers. These developments underpin a dynamic market environment where strategic partnerships and local manufacturing ventures play a pivotal role in capturing growth potential.

Highlighting Leading Atracurium Industry Players Strategic Positioning Product Portfolios and Collaborative Endeavors Shaping Competitive Landscapes and Growth Trajectories

Leading industry players in the atracurium domain are advancing their competitive positions through diversified portfolios, strategic alliances, and targeted research initiatives. Established pharmaceutical companies continue to leverage robust distribution networks to maintain market presence, while emerging specialized firms concentrate on formulation enhancements and niche application development. Collaborative research agreements with academic institutions and device manufacturers are facilitating integrated solutions that combine optimized dosing protocols with intelligent infusion systems.

Concurrently, partnerships between chemical suppliers and contract manufacturing organizations are driving production scalability and cost efficiencies. Mobile health integrators and data analytics providers are entering the landscape, offering real-time monitoring platforms that complement neuromuscular blockade management. This multidisciplinary convergence underscores the evolving nature of the competitive ecosystem, where innovation extends beyond the molecule to encompass services and digital capabilities that enhance clinical outcomes and operational agility.

Formulating Action-Oriented Strategic Recommendations for Industry Stakeholders to Capitalize on Emerging Atracurium Trends Enhance Market Positioning and Drive Sustainable Growth

Industry leaders are advised to proactively diversify raw material sourcing by cultivating alternative supplier relationships and investing in in-region production capabilities to fortify supply chain resilience. Embracing digital infusion management tools can optimize dosing precision and streamline clinical workflows, thereby differentiating service offerings and fostering stronger ties with end users.

Moreover, engaging early with regulatory authorities to anticipate evolving safety and labeling requirements will facilitate smoother market access and reinforce compliance credentials. Aligning commercial strategies with high-growth segments such as specialized surgical procedures and advanced intensive care applications can unlock incremental value. Finally, forging cross-sector collaborations with device and software partners will amplify product utility and support integrated care solutions that meet the demands of modern healthcare systems.

Outlining Robust Research Methodology Incorporating Comprehensive Data Collection Analytical Frameworks and Validation Protocols for Rigorous Atracurium Market Insights

This study employed a structured research framework combining qualitative and quantitative methodologies to ensure comprehensive and reliable insights. Primary research consisted of in-depth interviews with key opinion leaders including clinicians, procurement specialists, and regulatory experts, complemented by focused discussions with supply chain stakeholders. These perspectives were triangulated with secondary data collected from peer-reviewed journals, industry publications, and validated trade databases to construct a robust analytical foundation.

Data points were subject to rigorous triangulation processes, involving cross-verification among independent sources to minimize bias. Segmentation mapping protocols were applied to categorize market dynamics across application areas, end user groups, distribution pathways, dosage forms, and administration routes. Analysis teams further conducted scenario testing to assess the sensitivity of supply chain disruptions and tariff implications, ensuring that findings reflect plausible market trajectories under varying conditions.

Synthesizing Critical Findings and Strategic Takeaways to Provide a Cohesive Conclusion on Atracurium Market Evolution Opportunities and Strategic Imperatives for Stakeholders

In summation, atracurium maintains a pivotal position within critical care and surgical practice, driven by its unique pharmacological profile and expanding clinical applications. The market has entered a phase of dynamic transformation propelled by technological innovations in delivery systems, evolving regulatory landscapes, and macroeconomic forces such as newly enacted tariffs. Stakeholders must navigate complex segmentation layers and regional variations to capitalize on emerging opportunities.

Strategic imperatives include reinforcing supply chain resilience, leveraging data-driven dosing solutions, and forging partnerships that integrate product and service offerings. By synthesizing segmentation insights, regional dynamics, and competitive intelligence, decision makers can formulate targeted strategies that address both short-term challenges and long-term growth objectives. This comprehensive analysis provides the foundation for informed action in a rapidly evolving atracurium marketplace.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Application
    • Intensive Care
      • Diagnostic Procedures
      • Mechanical Ventilation
    • Surgical Procedures
      • Cardiovascular Surgery
      • General Surgery
      • Neurological Surgery
      • Orthopedic Surgery
  • End User
    • Ambulatory Surgery Centers
      • Hospital Affiliated Centers
      • Standalone Centers
    • Clinics
      • General Clinics
      • Specialty Clinics
    • Hospitals
      • Private Hospitals
      • Public Hospitals
  • Distribution Channel
    • Hospital Pharmacies
      • In-House Pharmacy
      • Outsourced Pharmacy
    • Online Pharmacies
      • Otc Pharmacies
      • Prescription Pharmacies
    • Retail Pharmacies
      • Chain Pharmacies
      • Independent Pharmacies
  • Form
    • Lyophilized Powder
      • Multi Dose Vial
      • Single Dose Vial
    • Pre-Filled Syringe
      • Single Dose Syringe
  • Route Of Administration
    • Intravenous
      • Bolus Injection
      • Continuous Infusion
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:

  • Pfizer Inc.
  • Fresenius Kabi AG
  • Baxter International Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Hikma Pharmaceuticals PLC
  • Sagent Pharmaceuticals, Inc.
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • Acella Pharmaceuticals, LLC

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Regional price competition driven by increasing availability of atracurium generics in emerging markets
5.2. Clinician preference shifts influenced by safety profiles in critically ill patient sedation with atracurium
5.3. Impact of novel packaging and ready-to-use formulations on hospital procurement of atracurium
5.4. Influence of supply chain disruptions on atracurium availability in intensive care units globally
5.5. Adoption of quality by design manufacturing practices to meet stringent global atracurium regulations
5.6. Growth of value based contracting and outcome based pricing models for neuromuscular blockade agents
5.7. Rising adoption of continuous infusion protocols for atracurium in COVID related ARDS management
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Atracurium Market, by Application
8.1. Introduction
8.2. Intensive Care
8.2.1. Diagnostic Procedures
8.2.2. Mechanical Ventilation
8.3. Surgical Procedures
8.3.1. Cardiovascular Surgery
8.3.2. General Surgery
8.3.3. Neurological Surgery
8.3.4. Orthopedic Surgery
9. Atracurium Market, by End User
9.1. Introduction
9.2. Ambulatory Surgery Centers
9.2.1. Hospital Affiliated Centers
9.2.2. Standalone Centers
9.3. Clinics
9.3.1. General Clinics
9.3.2. Specialty Clinics
9.4. Hospitals
9.4.1. Private Hospitals
9.4.2. Public Hospitals
10. Atracurium Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.2.1. In-House Pharmacy
10.2.2. Outsourced Pharmacy
10.3. Online Pharmacies
10.3.1. Otc Pharmacies
10.3.2. Prescription Pharmacies
10.4. Retail Pharmacies
10.4.1. Chain Pharmacies
10.4.2. Independent Pharmacies
11. Atracurium Market, by Form
11.1. Introduction
11.2. Lyophilized Powder
11.2.1. Multi Dose Vial
11.2.2. Single Dose Vial
11.3. Pre-Filled Syringe
11.3.1. Single Dose Syringe
12. Atracurium Market, by Route Of Administration
12.1. Introduction
12.2. Intravenous
12.2.1. Bolus Injection
12.2.2. Continuous Infusion
13. Americas Atracurium Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Atracurium Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Atracurium Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. Fresenius Kabi AG
16.3.3. Baxter International Inc.
16.3.4. Teva Pharmaceutical Industries Ltd.
16.3.5. Viatris Inc.
16.3.6. Hikma Pharmaceuticals PLC
16.3.7. Sagent Pharmaceuticals, Inc.
16.3.8. Cipla Limited
16.3.9. Sun Pharmaceutical Industries Ltd.
16.3.10. Acella Pharmaceuticals, LLC
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ATRACURIUM MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ATRACURIUM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ATRACURIUM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ATRACURIUM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ATRACURIUM MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ATRACURIUM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ATRACURIUM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ATRACURIUM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ATRACURIUM MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ATRACURIUM MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ATRACURIUM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ATRACURIUM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ATRACURIUM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ATRACURIUM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ATRACURIUM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ATRACURIUM MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ATRACURIUM MARKET: RESEARCHAI
FIGURE 26. ATRACURIUM MARKET: RESEARCHSTATISTICS
FIGURE 27. ATRACURIUM MARKET: RESEARCHCONTACTS
FIGURE 28. ATRACURIUM MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ATRACURIUM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ATRACURIUM MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ATRACURIUM MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ATRACURIUM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ATRACURIUM MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ATRACURIUM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ATRACURIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ATRACURIUM MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ATRACURIUM MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ATRACURIUM MARKET SIZE, BY MECHANICAL VENTILATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ATRACURIUM MARKET SIZE, BY MECHANICAL VENTILATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ATRACURIUM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ATRACURIUM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ATRACURIUM MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ATRACURIUM MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ATRACURIUM MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ATRACURIUM MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ATRACURIUM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ATRACURIUM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ATRACURIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ATRACURIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ATRACURIUM MARKET SIZE, BY STANDALONE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ATRACURIUM MARKET SIZE, BY STANDALONE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ATRACURIUM MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ATRACURIUM MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ATRACURIUM MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ATRACURIUM MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ATRACURIUM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ATRACURIUM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ATRACURIUM MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ATRACURIUM MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ATRACURIUM MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ATRACURIUM MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ATRACURIUM MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ATRACURIUM MARKET SIZE, BY IN-HOUSE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ATRACURIUM MARKET SIZE, BY IN-HOUSE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ATRACURIUM MARKET SIZE, BY OUTSOURCED PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ATRACURIUM MARKET SIZE, BY OUTSOURCED PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ATRACURIUM MARKET SIZE, BY OTC PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ATRACURIUM MARKET SIZE, BY OTC PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ATRACURIUM MARKET SIZE, BY PRESCRIPTION PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ATRACURIUM MARKET SIZE, BY PRESCRIPTION PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ATRACURIUM MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ATRACURIUM MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ATRACURIUM MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ATRACURIUM MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ATRACURIUM MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ATRACURIUM MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ATRACURIUM MARKET SIZE, BY MULTI DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ATRACURIUM MARKET SIZE, BY MULTI DOSE VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ATRACURIUM MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ATRACURIUM MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ATRACURIUM MARKET SIZE, BY SINGLE DOSE SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ATRACURIUM MARKET SIZE, BY SINGLE DOSE SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL ATRACURIUM MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL ATRACURIUM MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL ATRACURIUM MARKET SIZE, BY BOLUS INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL ATRACURIUM MARKET SIZE, BY BOLUS INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL ATRACURIUM MARKET SIZE, BY CONTINUOUS INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL ATRACURIUM MARKET SIZE, BY CONTINUOUS INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ATRACURIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS ATRACURIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS ATRACURIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS ATRACURIUM MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS ATRACURIUM MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS ATRACURIUM MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS ATRACURIUM MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS ATRACURIUM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES ATRACURIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES ATRACURIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES ATRACURIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES ATRACURIUM MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES ATRACURIUM MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES ATRACURIUM MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES ATRACURIUM MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES ATRACURIUM MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES ATRACURIUM MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 177. CANADA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. CANADA ATRACURIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. CANADA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2024 (USD MILLION)
TABLE 180. CANADA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2025-2030 (USD MILLION)
TABLE 181. CANADA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 182. CANADA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 183. CANADA ATRACURIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. CANADA ATRACURIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. CANADA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 186. CANADA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 187. CANADA ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 188. CANADA ATRACURIUM MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 189. CANADA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 190. CANADA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 191. CANADA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. CANADA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. CANADA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 194. CANADA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 195. CANADA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 196. CANADA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 197. CANADA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 198. CANADA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 199. CANADA ATRACURIUM MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 200. CANADA ATRACURIUM MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 201. CANADA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 202. CANADA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 203. CANADA ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 204. CANADA ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 205. CANADA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 206. CANADA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 207. CANADA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 208. CANADA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 209. MEXICO ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. MEXICO ATRACURIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. MEXICO ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2024 (USD MILLION)
TABLE 212. MEXICO ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2025-2030 (USD MILLION)
TABLE 213. MEXICO ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 214. MEXICO ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 215. MEXICO ATRACURIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. MEXICO ATRACURIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. MEXICO ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 218. MEXICO ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 219. MEXICO ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 220. MEXICO ATRACURIUM MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 221. MEXICO ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 222. MEXICO ATRACURIUM MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 223. MEXICO ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. MEXICO ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. MEXICO ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 226. MEXICO ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 227. MEXICO ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 228. MEXICO ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 229. MEXICO ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 230. MEXICO ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 231. MEXICO ATRACURIUM MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 232. MEXICO ATRACURIUM MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 233. MEXICO ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 234. MEXICO ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 235. MEXICO ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 236. MEXICO ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 237. MEXICO ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 238. MEXICO ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 239. MEXICO ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 240. MEXICO ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL ATRACURIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL ATRACURIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL ATRACURIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL ATRACURIUM MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL ATRACURIUM MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL ATRACURIUM MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL ATRACURIUM MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA ATRACURIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA ATRACURIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA ATRACURIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA ATRACURIUM MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA ATRACURIUM MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA ATRACURIUM MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 335. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 336. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 337. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 338. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 339. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 340. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 341. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2024 (USD MILLION)
TABLE 342. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2025-2030 (USD MILLION)
TABLE 343. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 344. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 345. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 346. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 347. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 348. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 349. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 350. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 351. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 352. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 353. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 354. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 355. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 356. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 357. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 358. UNITED KINGDOM ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 359. UNITED KINGD

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Atracurium market report include:
  • Pfizer Inc.
  • Fresenius Kabi AG
  • Baxter International Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Hikma Pharmaceuticals PLC
  • Sagent Pharmaceuticals, Inc.
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • Acella Pharmaceuticals, LLC

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 251.75 Million
Forecasted Market Value ( USD ) by 2030 $ 302.9 Million
Compound Annual Growth Rate3.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Atracurium Besylate (CAS 64228-81-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Atracurium Besylate (CAS 64228-81-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Cisatracurium Besilate Injection Market - Global Forecast 2025-2030 - Product Image

Cisatracurium Besilate Injection Market - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Local Anesthesia Drugs Market - Global Forecast 2025-2030 - Product Image

Local Anesthesia Drugs Market - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Global General Anesthesia Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global General Anesthesia Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 110 Pages
  • Global
From
General Anesthesia Drugs Market Size, Share & Trends Analysis Report By Drug (Propofol), By Route Of Administration (Intravenous), By End-use (Hospitals), By Application, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

General Anesthesia Drugs Market Size, Share & Trends Analysis Report By Drug (Propofol), By Route Of Administration (Intravenous), By End-use (Hospitals), By Application, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From

About the Atracurium Market

Atracurium is a neuromuscular blocking drug used in anesthetic drugs. It is a synthetic, short-acting, non-depolarizing muscle relaxant that is used to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It is also used to reduce the amount of anesthetic drugs needed during surgery. Atracurium is metabolized by the enzyme pseudocholinesterase, which is found in the plasma and liver. Atracurium is available in a variety of formulations, including injection, infusion, and inhalation. It is typically administered intravenously, but can also be administered intramuscularly or subcutaneously. The drug is available in both generic and branded forms. The Atracurium market is highly competitive, with several major players in the market. Some of the major companies in the market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.